(RTTNews) - Hanesbrands Inc. (HBI) shares are rising on Tuesday morning as its e-commerce performance is gaining momentum amid COVID-19 pandemic. The maker of underwear, intimate apparel, and activewear has been making use of the pandemic period by making facemasks.
The Luckin Coffee (OTC: LKNC.Y) saga continues as the company brings in a new chairman and CEO in place of chairman Charles Lu and former CEO Jenny Zhiya Qian.
The following are today's upgrades for Validea's Small-Cap Growth Investor model based on the published strategy of Motley Fool. This strategy looks for small cap growth stocks with solid fundamentals and strong price performance.
The following are today's upgrades for Validea's Earnings Yield Investor model based on the published strategy of Joel Greenblatt. This value model looks for companies with high return on capital and earnings yields.
The following are today's upgrades for Validea's P/E/Growth Investor model based on the published strategy of Peter Lynch. This strategy looks for stocks trading at a reasonable price relative to earnings growth that also possess strong balance sheets.
The following are today's upgrades for Validea's Growth/Value Investor model based on the published strategy of James P. O'Shaughnessy. This two strategy approach offers a large-cap value model and a growth approach that looks for persistent earnings growth and strong relative
The following are today's upgrades for Validea's Patient Investor model based on the published strategy of Warren Buffett. This strategy seeks out firms with long-term, predictable profitability and low debt that trade at reasonable valuations.
The following are today's upgrades for Validea's Price/Sales Investor model based on the published strategy of Kenneth Fisher. This value strategy rewards stocks with low P/S ratios, long-term profit growth, strong free cash flow and consistent profit margins.
The following are today's upgrades for Validea's Low PE Investor model based on the published strategy of John Neff. This strategy looks for firms with persistent earnings growth that trade at a discount relative to their earnings growth and dividend yield.
The following are today's upgrades for Validea's Contrarian Investor model based on the published strategy of David Dreman. This contrarian strategy finds the most unpopular mid- and large-cap stocks in the market and looks for improving fundamentals.
The following are today's upgrades for Validea's Growth Investor model based on the published strategy of Martin Zweig. This strategy looks for growth stocks with persistent accelerating earnings and sales growth, reasonable valuations and low debt.
The following are today's upgrades for Validea's Value Investor model based on the published strategy of Benjamin Graham. This deep value methodology screens for stocks that have low P/B and P/E ratios, along with low debt and solid long-term earnings growth.
Fresh from saying it was ready to invest as much as $10 billion in India over the next five to seven years, Alphabet's (NASDAQ: GOOG)(NASDAQ: GOOGL) Google is reportedly negotiating a $4 billion investment in telecom and internet provider Jio Platforms, a division of the country
A sports gambling legalization wave is under way. In May 2018, The Supreme Court overturned a federal law passed in 1992 that banned sports gambling in most states. Since then, 22 states (plus Washington, D.C.) have legalized the activity.
One company wants you to see the world. The other company wants you to show you its World. What if you can't have the best of both worlds? What if you could only own one? Booking Holdings (NASDAQ: BKNG) is the top dog when it comes to online travel portals. Disney (NYSE: DIS) is
The coronavirus pandemic revealed a major weakness in the business model of Diageo (NYSE: DEO), namely that its operations are too tied to restaurants, bars, and clubs. Because of the shutdown caused by the pandemic, 20% of Diageo's North American business was put at risk, as w
(RTTNews) - AutoNation Inc. (AN) said Tuesday that its chief executive officer Cheryl Miller has decided not to return from her leave of absence, and has resigned as of July 14, 2020. She has also resigned from the Board of Directors.
Intellia Therapeutics (NASDAQ: NTLA) is a biotech company that focuses on gene editing, a relatively new technology that could allow scientists to devise therapies for otherwise impossible-to-treat conditions. As with any new technology, those who invest in it early enough could